Telzuit Medical Technologies, Inc. Contracts With Medical Device Industry Expert For Bio-Patch Rollout

ORLANDO, Fla., Jan. 25 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. (the “Company” or “Telzuit”) today announced that the Company has signed a consulting agreement with Larry Goff, a veteran medical device engineer. Goff will spearhead the final phases of the roll-out of the Bio-Patch Wireless Holter Monitor for patient and physician use.

“As Telzuit launches its flagship medical device, it is critical that we complement our team with someone of Larry’s caliber and proven ability. He has built an exceptional track record in directing the development and launch of a broad range of breakthrough medical products. We look forward to working with Larry in executing on our vision for the Bio-Patch,” said Donald Sproat, President and CEO of Telzuit Medical Technologies, Inc.

Most recently, Goff was the Vice President of Engineering for Transmedics, Inc. While at Transmedics, Goff led the technical development team of the Organ Care System (OCS) used for transporting human hearts intended for transplantation. Prior to this, Goff headed up the Lifecare Division of Analogic Corp., where he created products as OEM designs for three Agilent and two Nellcor product lines, as well as Analogic branded products. While at Analogic, he also led development, transfer and manufacturing of several families of fetal heart monitors and multifunction patient monitors. Goff also had tenures at Texas Instruments and Burr-Brown Corp. as Engineering Manager responsible for technology support for in excess of $150 million in sales.

“I see great potential in helping Telzuit to make its unique concept of mobile monitoring a reality,” said Goff. “I’m excited to be involved in the implementation of Bio-Patch’s advanced wireless technology and look forward to moving the product to the next stage.”

About Telzuit Technologies, Inc.

Telzuit Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The first step in this mission will initially take the form of our state-of-the-art, FDA approved, Bio-Patch Wireless Heart Monitor. This is a full 12-lead, completely wireless, Holter monitor, which is new to the marketplace. Telzuit is also building its own dedicated intranet as a platform to handle several of the products it will be releasing, including its initial product, the Bio-Patch Wireless Heart Monitor. More information on Telzuit, its business model, and its products can be found on its website: http://www.telzuit.com, or call 407-354-1222.

Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact: Telzuit Medical Technologies, Inc. James Tolan 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (media) Todd St.Onge (investors) 212-986-6667

Telzuit Medical Technologies, Inc.

CONTACT: James Tolan of Telzuit Medical Technologies, Inc.,+1-407-354-1222; or Jennifer Gery - media, or Todd St.Onge - investors,both of Brainerd Communicators, Inc. for Telzuit Medical Technologies,Inc., +1-212-986-6667

MORE ON THIS TOPIC